Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review.

Bagkaki, Alena; Tsoutsinos, Alexandros; Hatzidaki, Eleftheria; Tzatzarakis, Manolis; Parthenakis, Fragiskos; Germanakis, Ioannis

Bagkaki, Alena; Tsoutsinos, Alexandros; Hatzidaki, Eleftheria; Tzatzarakis, Manolis; Parthenakis, Fragiskos; Germanakis, Ioannis.

Afiliação

Bagkaki A; Pediatric Cardiology Unit, Department of Pediatrics, School of Medicine, University Hospital Heraklion, University of Crete, Heraklion, Greece.
Tsoutsinos A; Department of Pediatric Cardiology and Adult Congenital Heart Disease, Onassis Cardiac Surgery Center, Athens, Greece.
Hatzidaki E; Department of Neonatology, School of Medicine, University Hospital Heraklion, University of Crete, Heraklion, Greece.
Tzatzarakis M; Laboratory of Toxicology, School of Medicine, University of Crete, Heraklion, Greece.
Parthenakis F; Department of Cardiology, School of Medicine, University Hospital Heraklion, University of Crete, Heraklion, Greece.
Germanakis I; Pediatric Cardiology Unit, Department of Pediatrics, School of Medicine, University Hospital Heraklion, University of Crete, Heraklion, Greece.

Front Pediatr ; 9: 674041, 2021.

Article em En | MEDLINE | ID: mdl-34504812

Palavras-chave

LQT syndrome; LQT3; QT prolongation; SCN5A mutation; case report; child; mexiletine; neonate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Pediatr Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google